These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 19839429)

  • 1. Neoadjuvant chemotherapy for resectable non-small-cell lung cancer.
    Gray J; Sommers E; Alvelo-Rivera M; Robinson L; Bepler G
    Oncology (Williston Park); 2009 Sep; 23(10):879-86. PubMed ID: 19839429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neoadjuvant therapy for resectable non-small cell lung cancer with mediastinal lymph node involvement.
    Tieu BH; Sanborn RE; Thomas CR
    Thorac Surg Clin; 2008 Nov; 18(4):403-15. PubMed ID: 19086609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoadjuvant chemotherapy for non-small cell lung cancer.
    Pinder-Schenck M; Bepler G
    Minerva Chir; 2009 Dec; 64(6):611-28. PubMed ID: 20029358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction or neoadjuvant therapy in resectable non-small cell lung cancer.
    Langer CJ
    Semin Oncol; 1999 Oct; 26(5 Suppl 15):34-9. PubMed ID: 10566609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy and radiotherapy in the treatment of resectable non-small-cell lung cancer.
    Bernstein ED; Herbert SM; Hanna NH
    Ann Surg Oncol; 2006 Mar; 13(3):291-301. PubMed ID: 16450219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy in the older patient with operable non-small cell lung cancer: neoadjuvant and adjuvant regimens.
    Browner I; Purtell M
    Thorac Surg Clin; 2009 Aug; 19(3):377-89. PubMed ID: 20066949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early-stage non-small-cell lung cancer: current perspectives in combined-modality therapy.
    Bunn PA
    Clin Lung Cancer; 2004 Sep; 6(2):85-98. PubMed ID: 15476594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chemotherapy in a multidisciplinary approach to the treatment of stage III non-small-cell bronchial cancers (NSCBC)].
    Milleron B; Depierre A
    Rev Mal Respir; 1998 Jun; 15(3 Pt 2):383-95. PubMed ID: 9690309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant treatment of non-small-cell lung cancer: how do we improve the cure rates further?
    Wozniak AJ; Gadgeel SM
    Oncology (Williston Park); 2007 Feb; 21(2):163-71; discussion 171, 174, 179-82. PubMed ID: 17396481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neoadjuvant chemotherapy in non-small cell lung cancer: current state and future].
    Mellas N; Elmesbahi O; Masbah O; Errihani H
    Bull Cancer; 2010 Feb; 97(2):211-23. PubMed ID: 20051349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Current status of the neo-adjuvant and adjuvant therapy for the resectable non-small cell lung cancer].
    Yamaguchi M; Fukuyama Y; Ichinose Y
    Gan To Kagaku Ryoho; 2003 Feb; 30(2):203-8. PubMed ID: 12610867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoadjuvant chemotherapy in the treatment of nonsmall-cell lung cancer.
    De Pauw R; van Meerbeeck JP
    Curr Opin Oncol; 2007 Mar; 19(2):92-7. PubMed ID: 17272979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Adjuvant treatment for early stages of non-small-cell lung carcinoma (NSCLC)].
    Papadakis E
    Rev Pneumol Clin; 2001 Nov; 57(5 Pt 2):S25-8. PubMed ID: 11924238
    [No Abstract]   [Full Text] [Related]  

  • 14. [Predicting efficacy of neoadjuvant cheomotherapy on resectable stage IIIA non-small cell lung cancer by multi-gene expressions].
    Cheng C; Wu YL; Gu LJ; Chen G; Weng YM; Feng WN; Zhong WZ
    Ai Zheng; 2005 Jul; 24(7):846-9. PubMed ID: 16004813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Adjuvant or neoadjuvant chemotherapy in non-small cell bronchial cancers? Arguments in favor of choosing neoadjuvant chemotherapy].
    Depierre A
    Rev Pneumol Clin; 2002 Nov; 58(5 Pt 2):3S33-6. PubMed ID: 12538933
    [No Abstract]   [Full Text] [Related]  

  • 16. More questions about neoadjuvant chemotherapy in lung cancer.
    Vallières E
    Oncology (Williston Park); 2009 Sep; 23(10):892, 896. PubMed ID: 19839431
    [No Abstract]   [Full Text] [Related]  

  • 17. Neoadjuvant chemotherapy for resectable non-small cell lung cancer.
    Finkelstein EJ; Urschel JD; Takita H
    J Exp Clin Cancer Res; 1997 Dec; 16(4):437-9. PubMed ID: 9505221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pneumonectomy after chemotherapy: morbidity, mortality, and long-term outcome.
    Alifano M; Boudaya MS; Salvi M; Collet JY; Dinu C; Camilleri-Broët S; Régnard JF
    Ann Thorac Surg; 2008 Jun; 85(6):1866-72; discussion 1872-3. PubMed ID: 18498785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction chemotherapy for resectable non-small-cell lung cancer.
    Patel JD; Blum MG; Argiris A
    Oncology (Williston Park); 2004 Nov; 18(13):1591-602; discussion 1602-3, 1606, 1611-2. PubMed ID: 15648293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of pneumonectomy after induction therapy for locally advanced non-small cell lung cancer.
    d'Amato TA; Ashrafi AS; Schuchert MJ; Alshehab DS; Seely AJ; Shamji FM; Maziak DE; Sundaresan SR; Ferson PF; Luketich JD; Landreneau RJ
    Ann Thorac Surg; 2009 Oct; 88(4):1079-85. PubMed ID: 19766784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.